FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Notes into shares

FIT Biotech Oy

Company release October 14, 2016 at 09.30 am EET

Conversion of FIT Biotech Oy's Convertible Notes into shares

On September 26, 2016, the Board of Directors of FIT Biotech Oy (hereinafter also the "Company") decided to establish Convertible Note and Warrant Programmes in order to implement the Convertible Notes with Warrants Funding Programme of up to EUR 12,480,000 between the Company and Bracknor Investment ("Bracknor").

The Company's board of directors has today resolved to approve Bracknor's request relating to the funding programme to convert EUR 30,000 worth of Convertible Notes into the Company's K shares.

Due to the conversion of the Convertible Notes, the Company issues 126,604 new K shares in the Company to Bracknor with the subscription price of EUR 0.24021.

As a result of the issue of the new K shares in the Company, the total number of shares in the Company will increase to 37,921,775 shares, and the share capital of the Company will be increased by EUR 29,999,83. After the issue of the new K shares in the Company, the Company's shares will be divided in share series as follows: 37,851,311 K shares, 5,229 A shares and 65,235 D shares.

The increase of the share capital and new K shares in the Company will be registered in the Trade Register on or about October 17, 2016 and the new K shares will be admitted to trading on First North Finland on or about October 18, 2016.

FIT BIOTECH OY

Board of Directors

For further information: Chairman of the Board of Directors Juha Vapaavuori E-mail: juha.vapaavuori@fitbiotech.com Tel: +358 50 372 0824

Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000

About FIT Biotech FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

DISTRIBUTION: NASDAQ OMX Helsinki Principal media

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 41

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
YSS Faces Legal Heat Over Misleading Investor Claims

Updated Category News Views 22

YSS Investors Navigate Legal Waters as Class Action Looms Taking a slug of coffee this morning and diving right into it—York Space Systems has found itself in hot water. They went public earlier this year with what was supposed to be a shining opportunity under the NYSE:YSS ticker, but it turns out that not everything in their IPO shined—and now SBS Law is stepping up...

Continue Reading
Tata's $450M Bet on India's AI Infrastructure

Updated Category News Views 53

The Big Bet on AI Infrastructure Here comes Tata Communications, tossing nearly USD 450 million into the pot, betting on a vision that could change India's digital backbone. This isn't just some drop in the bucket; they're talking about laying down 10,000 kilometers of fiber for India's AI super highway. It's a gutsy move, and frankly, it's about time someone shook things...

Continue Reading
Cohere's CAD $7 Billion Raise Signals AI Power Shift

Updated Category News Views 135

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

Continue Reading
BioMarin Strikes Deal for New Fabry Disease Therapy

Updated Category News Views 35

BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...

Continue Reading
Ball Corp to Steal the Spotlight at 2026 Baird Event

Updated Category News Views 40

Ball Corporation's Big Moment at Baird 2026 Did you hear the rumble in the aluminum jungle? That's Ball Corporation (NYSE: BALL) gearing up to take the stage at the Baird 2026 Global Industrial Conference on November 12. The big wigs, Ron Lewis and Dan Rabbitt, CEO and CFO respectively, will throw down some serious wisdom at 7:55 a.m. Central Time. What'll they cover?...

Continue Reading
IDrive Fortifies Data Protection with Top Certifications

Updated Category News Views 43

Ramping up Security in a Complex World Data protection isn’t just yesterday’s crucial task—it's today's battlefield and tomorrow's war. Companies like IDrive are stepping up to the plate, offering solutions that are as sturdy as a brick wall. In a world where data breaches and hackers lurk like wolves in the shadows, the demand for secure, compliant data protection...

Continue Reading
NeuroSense's Phase 3 Strategies for PrimeC Unveiled

Updated Category News Views 61

How NeuroSense Is Poised to Tackle ALS Treatment Picture this: a room full of people holding their breath, hoping that NeuroSense can deliver the breakthrough they’ve been inching toward. It’s the kind of moment that gives you goosebumps if you've been sloggin' through the biotech trenches. NeuroSense’s pitch at NEALS is more than just a dog and pony show—it's a...

Continue Reading
Bandwidth Welcomes Chip Schroeder: Key Board Makeover

Updated Category News Views 39

Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...

Continue Reading
Florida's Natural, Johnsonville Settle Bet Over Juice

Updated Category News Views 33

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...

Continue Reading

Top 5 Most Recently Viewed Articles

MT Sobek Unveils New Global Adventure Trips for 2026

Updated Category News Views 240

Explore New Global Adventure Trips for 2026 MT Sobek has been leading the way in immersive adventure travel since 1969. The company is excited to announce a spectacular lineup of new trips for 2026 that promise to captivate travelers around the globe. Designed for those seeking unique experiences, these adventurers can now book their journeys into nature and culture....

Continue Reading
Crawford Nickel Project Advances Under Ontario's New Framework

Updated Category News Views 100

Introduction to the Crawford Nickel Project Canada Nickel Company Inc. has exciting news regarding its Crawford Nickel Project, which has been officially recognized by the Province of Ontario. This milestone comes as part of Ontario's One Project, One Process (1P1P) framework, a major step forward for the mining sector. Understanding the One Project, One Process Framework...

Continue Reading
Celebrating 2024 AvaPrize Winners in Virtual Care Excellence

Updated Category News Views 189

AvaSure Honors the 2024 AvaPrize Winners for Virtual Care Excellence In the realm of healthcare innovation, AvaSure has made significant strides. The company, renowned for its leadership in acute virtual care, recently revealed the impressive roster of award recipients for the 2024 AvaPrize. This annual awards program, now in its eighth year, aims to acknowledge...

Continue Reading
Scilex Holding Company Sets New Record Date for Preferred Dividend

Updated Category News Views 122

Scilex Holding Company Announces New Dividend Record Date Scilex Holding Company (Nasdaq: SCLX) is recognized for its innovative efforts in the realm of non-opioid pain management products. Recently, the company made a significant announcement regarding an adjustment in the record date for its previously declared preferred stock dividend. This development is meaningful...

Continue Reading
What Investors Should Expect from Designer Brands' Earnings

Updated Category News Views 166

Anticipating Designer Brands' Earnings Release Designer Brands (NYSE: DBI) is set to reveal its quarterly earnings soon. As the announcement approaches, investors are keen to learn how the company has performed and what lies ahead for its financial future. Analyst Earnings Expectations Industry analysts have projected that Designer Brands will report an earnings per share...

Continue Reading